RBF Capital’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.05M Sell
100,000
-22,000
-18% -$504K 0.09% 197
2026
Q1
$2.69M Sell
122,000
-139,612
-53% -$2.43M 0.13% 145
2025
Q4
$3.08M Buy
261,612
+19,112
+8% +$245K 0.14% 142
2025
Q3
$3.84M Sell
242,500
-50,000
-17% -$725K 0.17% 126
2025
Q2
$3.35M Sell
292,500
-10,307
-3% -$116K 0.16% 132
2025
Q1
$4.1M Sell
302,807
-10,500
-3% -$174K 0.25% 106
2024
Q4
$5.29M Sell
313,307
-101,311
-24% -$1.97M 0.27% 86
2024
Q3
$8.43M Buy
414,618
+124,311
+43% +$2.54M 0.42% 50
2024
Q2
$6.55M Hold
290,307
0.38% 62
2024
Q1
$7.62M Buy
+290,307
New +$8.27M 0.43% 54

Other funds holding CC

RBF Capital's CC Position: Q2 2026 in Review

RBF Capital reduced its Chemours (CC) stake by 18% in Q2 2026, selling an estimated $504K and leaving 100,000 shares worth $2.05M. The position accounts for 0.09% of the portfolio, ranked #197.

RBF Capital first reported a position in CC in Q1 2024 and has held it in 10 quarters since. The position peaked at $8.43M in Q3 2024. 471 funds tracked by Wall St. Rank hold CC as of Q2 2026.

  • RBF Capital held 100,000 shares of Chemours worth $2.05M as of Q2 2026.
  • RBF Capital sold 22,000 Chemours shares in Q2 2026, an estimated $504K.
  • Chemours made up 0.09% of RBF Capital's portfolio in Q2 2026, its #197 holding.
  • RBF Capital first reported a position in Chemours in Q1 2024 and has held it in 10 quarters since.
  • RBF Capital's Chemours position peaked at $8.43M in Q3 2024.
  • 471 funds tracked by Wall St. Rank held Chemours as of Q2 2026.

Based on RBF Capital's 13F filing for Q2 2026, filed 14 Aug 2026.